89 related articles for article (PubMed ID: 32097194)
21. Case report of human immunodeficiency virus infection, Hodgkin lymphoma, and pregnancy.
Israel R; Dorer R; Aboulafia DM
Am J Med Sci; 2010 Feb; 339(2):185-7. PubMed ID: 20019583
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin lymphoma in the Swiss HIV Cohort Study.
Clifford GM; Rickenbach M; Lise M; Dal Maso L; Battegay M; Bohlius J; Boffi El Amari E; Karrer U; Jundt G; Bordoni A; Ess S; Franceschi S;
Blood; 2009 Jun; 113(23):5737-42. PubMed ID: 19336755
[TBL] [Abstract][Full Text] [Related]
23. HIV and Hodgkin Lymphoma Survival: A Prospective Study in Botswana.
Moahi K; Ralefala T; Nkele I; Triedman S; Sohani A; Musimar Z; Efstathiou J; Armand P; Lockman S; Dryden-Peterson S
JCO Glob Oncol; 2022 Jan; 8():e2100163. PubMed ID: 35025689
[TBL] [Abstract][Full Text] [Related]
24. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
[TBL] [Abstract][Full Text] [Related]
25. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.
Biggar RJ; Jaffe ES; Goedert JJ; Chaturvedi A; Pfeiffer R; Engels EA
Blood; 2006 Dec; 108(12):3786-91. PubMed ID: 16917006
[TBL] [Abstract][Full Text] [Related]
26. Longer duration of combination antiretroviral therapy reduces the risk of Hodgkin lymphoma: A cohort study of HIV-infected male veterans.
Kowalkowski MA; Mims MA; Day RS; Du XL; Chan W; Chiao EY
Cancer Epidemiol; 2014 Aug; 38(4):386-92. PubMed ID: 24947588
[TBL] [Abstract][Full Text] [Related]
27. Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma.
Xicoy B; Ribera JM; Miralles P; Berenguer J; Rubio R; Mahillo B; Valencia ME; Abella E; López-Guillermo A; Sureda A; Morgades M; Navarro JT; Esteban H; ;
Haematologica; 2007 Feb; 92(2):191-8. PubMed ID: 17296568
[TBL] [Abstract][Full Text] [Related]
28. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
McGrath N; Lessells RJ; Newell ML
HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
[TBL] [Abstract][Full Text] [Related]
29. Interleukine-2 therapy does not increase the risk of Hodgkin or non-Hodgkin lymphoma in HIV-infected patients: results from FHDH ANRS CO4.
Fontas E; Kousignian I; Pradier C; Duvivier C; Poizot-Martin I; Durier C; Jarrousse B; Weiss L; Levy Y; Costagliola D;
J Acquir Immune Defic Syndr; 2009 Feb; 50(2):206-14. PubMed ID: 19131886
[TBL] [Abstract][Full Text] [Related]
30. Impact of systematic HIV testing on case finding and retention in care at a primary care clinic in South Africa.
Clouse K; Hanrahan CF; Bassett J; Fox MP; Sanne I; Van Rie A
Trop Med Int Health; 2014 Dec; 19(12):1411-9. PubMed ID: 25244155
[TBL] [Abstract][Full Text] [Related]
31. Growth curve modelling to determine distinct BMI trajectory groups in HIV-positive adults on antiretroviral therapy in South Africa.
Brennan AT; Berry KM; Rosen S; Stokes A; Crowther NJ; George J; Raal F; Cassim N; Sanne I; Long L; Fox MP
AIDS; 2019 Nov; 33(13):2049-2059. PubMed ID: 31577571
[TBL] [Abstract][Full Text] [Related]
32. The utility of bone marrow sampling in the diagnosis and staging of lymphoma in South Africa.
Phillips L; Opie J
Int J Lab Hematol; 2018 Jun; 40(3):276-283. PubMed ID: 29427399
[TBL] [Abstract][Full Text] [Related]
33. Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg, South Africa.
Shearer K; Evans D; Xhosa B; Hirasen K; Bracken C; Mahomed K; Long L; Fox MP
PLoS One; 2018; 13(9):e0203797. PubMed ID: 30252844
[TBL] [Abstract][Full Text] [Related]
34. High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.
Besson C; Lancar R; Prevot S; Brice P; Meyohas MC; Marchou B; Gabarre J; Bonnet F; Goujard C; Lambotte O; Boué F; Mounier N; Partisani M; Raffi F; Costello R; Hendel-Chavez H; Algarte-Genin M; Trabelsi S; Marchand L; Raphael M; Taoufik Y; Costagliola D
Clin Infect Dis; 2015 Nov; 61(9):1469-75. PubMed ID: 26223997
[TBL] [Abstract][Full Text] [Related]
35. Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy.
Gutiérrez-Saborido D; Gutiérrez-Valencia A; González Domenech CM; López Ruz MÁ; Raffo Márquez M; Omar M; Girón-González JA;
Ann Hematol; 2019 Aug; 98(8):1953-1959. PubMed ID: 31025161
[TBL] [Abstract][Full Text] [Related]
36. Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010.
Ndlovu Z; Chirwa T; Takuva S
Pan Afr Med J; 2014; 19():114. PubMed ID: 25722787
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy.
Olszewski AJ; Castillo JJ
AIDS; 2016 Mar; 30(5):787-96. PubMed ID: 26730566
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
Castillo JJ; Bower M; Brühlmann J; Novak U; Furrer H; Tanaka PY; Besson C; Montoto S; Cwynarski K; Abramson JS; Dalia S; Bibas M; Connors JM; Furman M; Nguyen ML; Cooley TP; Beltran BE; Collins JA; Vose JM; Xicoy B; Ribera JM;
Cancer; 2015 Feb; 121(3):423-31. PubMed ID: 25251326
[TBL] [Abstract][Full Text] [Related]
39. Markers of poor adherence among adults with HIV attending Themba Lethu HIV Clinic, Helen Joseph Hospital, Johannesburg, South Africa.
Nnambalirwa M; Govathson C; Evans D; McNamara L; Maskew M; Nyasulu P
Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):696-704. PubMed ID: 28938050
[TBL] [Abstract][Full Text] [Related]
40. Predicting the Need for Third-Line Antiretroviral Therapy by Identifying Patients at High Risk for Failing Second-Line Antiretroviral Therapy in South Africa.
Onoya D; Nattey C; Budgell E; van den Berg L; Maskew M; Evans D; Hirasen K; Long LC; Fox MP
AIDS Patient Care STDS; 2017 May; 31(5):205-212. PubMed ID: 28445088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
